Bank of America’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.77M Sell
1,663,490
-45,919
-3% -$214K ﹤0.01% 2943
2025
Q1
$9.38M Buy
1,709,409
+717,752
+72% +$3.94M ﹤0.01% 2725
2024
Q4
$3.36M Sell
991,657
-17,544
-2% -$59.5K ﹤0.01% 3362
2024
Q3
$2.88M Buy
1,009,201
+367,535
+57% +$1.05M ﹤0.01% 3599
2024
Q2
$1.44M Buy
641,666
+13,619
+2% +$30.6K ﹤0.01% 3969
2024
Q1
$1.39M Buy
628,047
+367,668
+141% +$813K ﹤0.01% 3963
2023
Q4
$612K Buy
260,379
+190,592
+273% +$448K ﹤0.01% 4489
2023
Q3
$130K Buy
69,787
+57,418
+464% +$107K ﹤0.01% 5256
2023
Q2
$32.4K Sell
12,369
-35,217
-74% -$92.3K ﹤0.01% 5725
2023
Q1
$77.6K Sell
47,586
-46,411
-49% -$75.7K ﹤0.01% 5553
2022
Q4
$125K Buy
93,997
+18,058
+24% +$24K ﹤0.01% 5396
2022
Q3
$119K Sell
75,939
-35,532
-32% -$55.7K ﹤0.01% 5451
2022
Q2
$172K Buy
111,471
+64,630
+138% +$99.7K ﹤0.01% 5434
2022
Q1
$120K Buy
46,841
+17,133
+58% +$43.9K ﹤0.01% 5991
2021
Q4
$87K Buy
29,708
+15,284
+106% +$44.8K ﹤0.01% 6105
2021
Q3
$35K Sell
14,424
-39,691
-73% -$96.3K ﹤0.01% 6305
2021
Q2
$220K Buy
54,115
+26,666
+97% +$108K ﹤0.01% 5269
2021
Q1
$124K Buy
27,449
+15,634
+132% +$70.6K ﹤0.01% 5629
2020
Q4
$58K Sell
11,815
-89,684
-88% -$440K ﹤0.01% 5512
2020
Q3
$602K Buy
101,499
+86,000
+555% +$510K ﹤0.01% 4020
2020
Q2
$41K Buy
15,499
+8,604
+125% +$22.8K ﹤0.01% 5483
2020
Q1
$13K Sell
6,895
-422
-6% -$796 ﹤0.01% 5678
2019
Q4
$52K Sell
7,317
-2,929
-29% -$20.8K ﹤0.01% 5421
2019
Q3
$101K Buy
10,246
+4,298
+72% +$42.4K ﹤0.01% 5230
2019
Q2
$68K Sell
5,948
-12,315
-67% -$141K ﹤0.01% 5406
2019
Q1
$184K Buy
18,263
+13,209
+261% +$133K ﹤0.01% 4842
2018
Q4
$86K Buy
5,054
+4,090
+424% +$69.6K ﹤0.01% 5252
2018
Q3
$17K Buy
+964
New +$17K ﹤0.01% 5799